Anti-viral pills have emerged as a viable treatment for Covid-19, with experts saying Pfizer's Paxlovid is the best bet against Omicron, the new variant of concern that has sent cases soaring across the globe. But the experimental pill is yet to be approved in India. In fact, two of the three anti-viral pills to tackle Covid-19 are not available in India; only Molnupiravir has been rolled out in the country. Here's a look at how soon these pills will reach India and the treatment protocol.